Earningsreport

Q4/2024 12/31/2024 EPS -0.650 ZacksConsensus -0.870 ActVsEst 0.220 - Beat

Inovio Pharmaceuticals, Inc.  (INO) 
NASDAQ:AMEX Investor Relations: ir.inovio.com/investors/default.aspx